Albert Einstein Coutinho dos Santos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Albert Einstein Coutinho dos Santos Santos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Diego Lisboa Cardoso
Federal University of Para
2 shared publications Erminio Paixao
Institute of Technology, Federal University of Pará, Belém, PA, Brazil
1 shared publication- Ermínio Augusto Ramos da Paixão
Institute of Technology, Federal University of Par, Belm, Par, Brazil
1 shared publication Fernando Augusto R. Costa
Center for Higher Amazon Studies, Federal University of Para, Belém, PA, Brazil
1 shared publication- Igor Wenner Silva Falcao
Universidade federal do Pará
1 shared publication Karla Figueiredo
Computer Science, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
1 shared publication
Latest Publications
- Open Access
- 11 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 13, 146810-146819
Network Selection in B5G Heterogeneous Networks Using AHP-TOPSIS
The implementation of ultra-dense heterogeneous networks (HetNets) has become crucial to meet the increasing demands of 5G and beyond networks. These networks face complex challenges due to the proliferation of mobile devices, network overlay, and high mobility. In this context, it is essential to identify the most suitable network for a given user, taking into consideration the user’s specific requirements. This article proposes a multi-criteria method for dynamic and personalized network selection in the context of different technologies, highlighting the difficulty involved in deciding which access technology the user should connect to. The proposed model showed better performance for high QoS (Quality of Service) profiles and low energy consumption, and it facilitated a more efficient distribution of network resources considering the network load criterion. A comparison with another current method in the literature highlighted the efficiency of the proposed model in achieving improvements for all user profiles considered.
- 11 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 13, 146810-146819
Open AccessNetwork Selection in B5G Heterogeneous Networks Using AHP-TOPSIS
The implementation of ultra-dense heterogeneous networks (HetNets) has become crucial to meet the increasing demands of 5G and beyond networks. These networks face complex challenges due to the proliferation of mobile devices, network overlay, and high mobility. In this context, it is essential to identify the most suitable network for a given user, taking into consideration the user’s specific requirements. This article proposes a multi-criteria method for dynamic and personalized network selection in the context of different technologies, highlighting the difficulty involved in deciding which access technology the user should connect to. The proposed model showed better performance for high QoS (Quality of Service) profiles and low energy consumption, and it facilitated a more efficient distribution of network resources considering the network load criterion. A comparison with another current method in the literature highlighted the efficiency of the proposed model in achieving improvements for all user profiles considered.
- Open Access
- 14 October 2024
- Published by PeerJ in PeerJ Computer Science
- Vol. 10, e2246
Model for predicting drug resistance based on the clinical profile of tuberculosis patients using machine learning techniques
Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis and despite effective treatments, still affects millions of people worldwide. The advent of new treatments has not eliminated the significant challenge of TB drug resistance. Repeated and inadequate exposure to drugs has led to the development of strains of the bacteria that are resistant to conventional treatments, making the eradication of the disease even more complex. In this context, it is essential to seek more effective approaches to fighting TB. This article proposes a model for predicting drug resistance based on the clinical profile of TB patients, using machine learning techniques. The model aims to optimize the work of health professionals directly involved with tuberculosis patients, driving the creation of new containment strategies and preventive measures, as it specifies the clinical data that has the greatest impact and identifies the individuals with the greatest predisposition to develop resistance to anti-tuberculosis drugs. The results obtained show, in one of the scenarios, a probability of development of 70% and an accuracy of 84.65% for predicting drug resistance.
- 14 October 2024
- Published by PeerJ in PeerJ Computer Science
- Vol. 10, e2246
Open AccessModel for predicting drug resistance based on the clinical profile of tuberculosis patients using machine learning techniques
Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis and despite effective treatments, still affects millions of people worldwide. The advent of new treatments has not eliminated the significant challenge of TB drug resistance. Repeated and inadequate exposure to drugs has led to the development of strains of the bacteria that are resistant to conventional treatments, making the eradication of the disease even more complex. In this context, it is essential to seek more effective approaches to fighting TB. This article proposes a model for predicting drug resistance based on the clinical profile of TB patients, using machine learning techniques. The model aims to optimize the work of health professionals directly involved with tuberculosis patients, driving the creation of new containment strategies and preventive measures, as it specifies the clinical data that has the greatest impact and identifies the individuals with the greatest predisposition to develop resistance to anti-tuberculosis drugs. The results obtained show, in one of the scenarios, a probability of development of 70% and an accuracy of 84.65% for predicting drug resistance.